Australia markets closed

ResMed Inc. (RMD.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
23.60-0.50 (-2.07%)
At close: 05:10PM AEDT
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in USD. All numbers in thousands
Breakdown
ttm
30/06/2023
30/06/2022
30/06/2021
30/06/2020
Total revenue
4,222,993
4,222,993
3,578,127
3,196,825
2,957,013
Cost of revenue
1,867,331
1,867,331
1,553,816
1,357,725
1,239,227
Gross profit
2,355,662
2,355,662
2,024,311
1,839,100
1,717,786
Operating expenses
Research development
287,642
287,642
253,575
225,284
201,946
Selling general and administrative
874,003
874,003
739,372
670,387
676,689
Total operating expenses
1,203,665
1,203,665
1,024,025
926,749
908,727
Operating income or loss
1,151,997
1,151,997
1,000,286
912,351
809,059
Interest expense
-
-
-
23,989
40,377
Total other income/expenses net
-2,954
-2,954
-17,491
-5,062
-36,615
Income before tax
1,101,664
1,101,664
960,483
883,662
733,088
Income tax expense
204,108
204,108
181,046
409,157
111,414
Income from continuing operations
897,556
897,556
779,437
474,505
621,674
Net income
897,556
897,556
779,437
474,505
621,674
Net income available to common shareholders
897,556
897,556
779,437
474,505
621,674
Basic EPS
-
0.61
0.53
0.33
0.43
Diluted EPS
-
0.61
0.53
0.32
0.43
Basic average shares
-
1,467,650
1,460,660
1,453,130
1,443,380
Diluted average shares
-
1,474,550
1,470,430
1,464,510
1,456,520